Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784641 · ClinicalTrials.gov registry record · NA
A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 567
- Enrollment target
NCT00784641: Completed NA study, sponsored by Bausch & Lomb Incorporated.
NCT00784641 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 567 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00784641, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 567 participants
- Enrollment target
Study Summary
Evaluation of the clinical performance of a novel Bausch \& Lomb daily disposable contact lens when compared to the currently marketed Bausch \& Lomb SofLens® daily disposable contact lenses and the currently marketed Johnson and Johnson 1-Day Acuvue Moist contact lenses when worn by adapted soft contact lens wearers on a daily disposable basis.
Primary Outcome
The initial lens performance survey was administered at the Screening/Dispensing Visit. Scores were captured on a scale from 0 to 100, with 100 being the most favorable score. Favorable responses were defined as scores of 80 or greater.
Interventions
- DEVICE Novel Bausch & Lomb daily disposable contact lenses
- DEVICE Bausch & Lomb SofLens daily disposable contact lenses.
- DEVICE Johnson and Johnson 1-Day Acuvue Moist contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 567 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-01 |
| Phase | NA |
What the finished NCT00784641 record still lists
NCT00784641 is an interventional study that assigns participants to a tested intervention. The registered 567 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 3 interventions - of which Novel Bausch & Lomb daily disposable contact lenses is the first listed.
NCT00784641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00784641 about?
NCT00784641 is a clinical study titled "A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use". Evaluation of the clinical performance of a novel Bausch \& Lomb daily disposable contact lens when compared to the currently marketed Bausch \& Lomb SofLens® daily disposable contact lenses and the currently marketed Johnson and Johnson 1-Day Acuvue Moist contact lenses when worn by adapted soft co...
What is the current status of trial NCT00784641?
This trial is currently completed. It is a NA study. The enrollment target is 567 participants. The study started on 2008-11. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00784641?
The interventions under investigation include: Novel Bausch & Lomb daily disposable contact lenses (DEVICE), Bausch & Lomb SofLens daily disposable contact lenses. (DEVICE), Johnson and Johnson 1-Day Acuvue Moist contact lenses (DEVICE).
Who is sponsoring clinical trial NCT00784641?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00784641's enrollment target sits among peer trials
567 180th of 2000 higher than 1,821 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05472441 · 568 participants · NA
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia